|
The detailed patient data. |
|||||||
| Case number |
Gender |
Diagnosis |
Result |
Reported/Novel |
HRM result |
FVIII:C |
Severity |
|
|
|||||||
| 69-1 |
M |
Affected case |
Exon 1 deletion |
R |
<1% |
severe |
|
| 61-1 |
M |
Affected case |
Exon 2, c.185, C>G, TCA>TGA, Ser>X |
N |
<1% |
severe |
|
| 109 |
M |
Affected case |
Exon 3, c.278, C>T, CCT>CTT, Pro>Leu |
N |
V |
<1% |
severe |
| 82 |
M |
Affected case |
Exon 3, c.278, C>T, CCT>CTT, Pro>Leu |
N |
<1% |
severe |
|
| 144 |
M |
Affected case |
Exon 3, c.336_339, dup CCAT |
N |
indistinguishable |
1.6% |
moderate |
| 71-1 |
F |
Carrier |
Intron 3, c.289-9 C>T |
N |
V |
||
| 42-3 |
M |
Affected case |
Exon 4, c.403 G>A, GAT>AAT, Asp>Asn |
N |
<1% |
severe |
|
| 59-1 |
M |
Affected case |
Exon 4, c.532, C>G, CTT>GTT, Leu>Val |
N |
<1% |
severe |
|
| 118-1 |
M |
Affected case |
Exon 4~Exon 10 deletion |
R |
1.1% |
moderate |
|
| 122 |
M |
Affected case |
Exon 7, c.829, A>G, ATT>GTT, Asp>Gly |
N |
V |
12% |
muld |
| 114 |
M |
Affected case |
Exon 7, c.854_855, ins G |
N |
V |
2.4% |
moderate |
| 79-1 |
M |
Affected case |
Exon 7, c.977 T>C, CTA>CCA, Leu>Pro |
R |
<1% |
severe |
|
| 94-1 |
M |
Affected case |
Exon 7, c.977 T>C, CTA>CCA, Leu>Pro |
R |
<1% |
severe |
|
| 16-3 |
M |
Affected case |
Exon 8, c.1247, C>T, CCC>CTC, Pro>Leu |
N |
4.2% |
moderate |
|
| 101 |
F |
Carrier |
Exon 9, c.1310 G>C, CGG>CCG, Arg>Pro |
R |
V |
||
| 72-1 |
M |
Affected case |
Exon 9, c.1315 G>A, GGT>AGT, Gly>Ser |
R |
3.0% |
moderate |
|
| 162 |
M |
Affected |
Exon 9, c.1336, C>T, CGA>TGA, Arg>X |
R |
4.8% |
moderate |
|
| 110 |
M |
Affected case |
Exon 9, c.1400, T>G, ATC>AGC, Ile>Ser |
N |
V |
0.6% |
severe |
| 65 |
M |
Affected case |
Exon 11, c.1636, C>T, CGG>TGG, Arg>Trp |
R |
2.3% |
moderate |
|
| 92 |
M |
Affected case |
Exon 11, c.1648, C>T, CGC>TGC, Arg>Cys |
R |
12.0% |
mild |
|
| 136 |
M |
Affected case |
Exon 11, c.1678, A>G, AGA>GAA, Arg>Gly |
N |
V |
11.0% |
moderate |
| 98 |
M |
Affected case |
Exon 12, c.1783_1790 del 8 mer |
N |
V |
<1% |
severe |
| 119 |
M |
Affected case |
Exon 12, c.1804, C>T, CGA>TGA.Arg>X |
R |
V |
1.5% |
moderate |
| 150-1 |
M |
Affected case |
Exon 12, c.1834, C>T, CGC>TGC, Arg>Cys |
R |
6.0% |
mild |
|
| 10-1 |
M |
Affected case |
Exon 14, c.2314 C>T, CAA>TAA, Gln>X |
R |
<1% |
severe |
|
| 104-1 |
M |
Affected case |
Exon 14, c.2605_2606, ins C |
N |
V |
<1% |
severe |
| 113-1 |
M |
Affected case |
Exon 14, c.2609_2610, del CT |
R |
V |
<1% |
severe |
| 85-1 |
M |
Affected case |
Exon 14, c.2939_2940, ins G |
N |
V |
<1% |
severe |
| 124 |
M |
Affected case |
Exon 14, c.3294_3295, ins A |
N |
V |
0.2% |
severe |
| 111 |
M |
Affected case |
Exon 14, c.3629, del A |
R |
V |
<1% |
severe |
| 17-1 |
F |
Carrier |
Exon 14, c.3629, del A |
R |
|||
| 3-1 |
M |
Affected case |
Exon 14, c.3629, del A |
R |
<1% |
severe |
|
| 132 |
M |
Affected case |
Exon 14, c.4076 G>A, TGG>TAG, Trp>X |
R |
0.3% |
severe |
|
| 87-1 |
M |
Affected case |
Exon 14, c.4197 del C |
N |
3.0% |
moderate |
|
| 63-1 |
M |
Affected case |
Exon 14, c.4372, del A |
N |
3.6% |
moderate |
|
| 2-1 |
M |
Affected case |
Exon 14, c.4619, del T |
N |
<1% |
severe |
|
| 11-1 |
F |
Affected case |
Exon14, c.4814, C>A, TCA>TAA, Ser>X |
R |
2.0% |
moderate |
|
| 57-2 |
M |
Affected case |
Exon 14, c.4856, del C |
R |
<1% |
severe |
|
| 67-3 |
M |
Affected case |
Exon 14, c.4942 C>T, CAA>TAA, Gln>X |
2.6% |
moderate |
||
| 115-1 |
M |
Affected case |
Exon 14, c.5069_5073, del 5 mer |
R |
V |
<1% |
severe |
| 74 |
M |
Affected case |
Exon14, c.5143, C>T, CGA>TGA, Arg>X |
N |
<1% |
severe |
|
| 39-3 |
M |
Affected case |
Exon 15, c5343 T>A, TATA>TAA, Tyr>X |
N |
<1% |
severe |
|
| 48-5 |
M |
Affected case |
Exon 15, c.5353, G>A, GAA>AAA, Glu>Lys |
N |
V |
3.7% |
moderate |
| 159-2 |
M |
Affected case |
Exon 16, c.5399, G>A, CGT>CAT, Arg>His |
R |
4.5% |
moderate |
|
| 97 |
M |
Affected case |
Exon 16, c.5465_5466, insA |
N |
4.9% |
moderate |
|
| 55-1 |
M |
Affected case |
Exon 16, c.5526, G>A, ATG>ATA, Met>Ile |
R |
2.1% |
moderate |
|
| 5-2 |
M |
Affected case |
Exon 16, c.5536, T>A, AAA>TAA, Lys>X |
R |
1.6% |
moderate |
|
| 123 |
M |
Affected case |
Exon 16, c.5576, A>G, GAT>GGT, Asp>Gly |
N |
indistinguishable |
1.3% |
moderate |
| 161-1 |
F |
Carrier |
Exon 17, c.5711, A>G, GAG>GGG, Glu>Gly |
N |
V |
||
| 56-1 |
M |
Affected case |
Exon 17, c.5848, C>T, CGA>CAA, Gln>X |
N |
<1% |
severe |
|
| 1-1 |
M |
Affected case |
Exon 18, c.5879, G>A, CGA>CAA, Arg>Gln |
R |
7.4% |
mild |
|
| 133 |
M |
Affected case |
Exon 18, c.5879, G>A, CGA>CAA, Arg>Gln |
R |
5.5% |
mild |
|
| 107-1 |
M |
Affected case |
Exon 18, c.5953, C>T, CGA>TGA, Arg>X |
R |
V |
0.8% |
severe |
| 138-2 |
M |
Affected case |
Exon 18, c.5953, C>T, CGA>TGA, Arg>X |
R |
<1% |
severe |
|
| 73 |
M |
Affected case |
Exon 22, c.6403, C>T, CGA>TGA, Arg>X |
N |
<1% |
severe |
|
| 14-2 |
M |
Affected case |
Exon 23, c.6506, G>A, CGT>CAT, Arg>His |
R |
25% |
mild |
|
| 20-1 |
M |
Affected case |
Exon 23, c.6506, G>A, CGT>CAT, Arg>His |
R |
2.9% |
moderate |
|
| 139-1 |
M |
Affected case |
Exon 23, c.6506, G>A, CGT>CAT, Arg>His |
R |
V |
3.0% |
moderate |
| 125 |
M |
Affected case |
Exon 23, c.6532, C>T, CGC>TGC, Arg>Cys |
R |
6.5% |
mild |
|
| 170-1 |
M |
Affected case |
Exon 23, c.6532 C>T, CGC>TGC, Arg>Cys |
R |
V |
8.9% |
mild |
| 174-1 |
M |
Affected case |
Exon 23, c.6532 C>T, CGC>TGC, Arg>Cys |
R |
V |
8.4% |
mild |
| 95-1 |
M |
Affected case |
Exon 23, c.6545, G>A, CGC>CAC, Arg>His |
R |
V |
2.5% |
moderate |
| 38-3 |
M |
Affected case |
Exon 24, c. 6575 G>T, AGT>ATT, Ser>Ile |
R |
7.2% |
mild |
|
| 102-1 |
M |
Affected case |
Exon 24, c.6671, C>T, CCT>CTT, Pro>Leu |
R |
V |
2.7% |
moderate |
| 12-1 |
F |
Affected case |
Exon 24, c.6683 G>A, CGA> CAA, Arg>Gln |
R |
<1% |
severe |
|
| 41-3 |
M |
Affected case |
Exon 25, c.6724, G>A, GTG>ATG, Val>Met; Exon 8, c.1172, G>A, CGC>CAC, Arg>His |
R;R |
indistibuishable; V |
<1% |
severe |
| 84-1 |
M |
Affected case |
Exon 25, c.6794_6795 del AG |
R |
indistinguishable |
<1% |
severe |
| 93-1 |
M |
Affected case |
Intron 1 inversion |
R |
12.0% |
mild |
|
| 21-1 |
M |
Affected case |
Intron 22 inversion/Exon14 c.4531, G>A, GTT>ATT, Val>Ile |
R;N |
V |
<1% |
severe |
| 100 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 103-1 |
F |
Carrier |
Intron 22 inversion |
R |
|||
| 105 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 106-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 112-1 |
M |
Affected case |
Intron 22 inversion |
R |
1.2% |
moderate |
|
| 116-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 117 |
M |
Affected case |
Intron 22 inversion |
R |
3.0% |
moderate |
|
| 120-1 |
M |
Affected case |
Intron 22 inversion |
R |
2.0% |
moderate |
|
| 121 |
M |
Affected case |
Intron 22 inversion |
R |
0.6% |
severe |
|
| 126-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 131-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 13-4 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 140 |
M |
Affected case |
Intron 22 inversion |
R |
1.1% |
moderate |
|
| 143-1 |
M |
Affected case |
Intron 22 inversion |
R |
3.0% |
moderate |
|
| 147 |
M |
Affected case |
Intron 22 inversion |
R |
0.5% |
severe |
|
| 149-2 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 151 |
M |
Affected case |
Intron 22 inversion |
R |
1.4% |
moderate |
|
| 15-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 152 |
M |
Affected case |
Intron 22 inversion |
R |
2.1% |
moderate |
|
| 153 |
M |
Affected case |
Intron 22 inversion |
R |
1.8% |
moderate |
|
| 154 |
M |
Affected case |
Intron 22 inversion |
R |
0.5% |
severe |
|
| 155 |
M |
Affected case |
Intron 22 inversion |
R |
1.7% |
moderate |
|
| 156 |
M |
Affected case |
Intron 22 inversion |
R |
1.8% |
moderate |
|
| 164 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 167 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 181 |
M |
Affected case |
Intron 22 inversion |
R |
3.0% |
moderate |
|
| 31-7 |
F |
Carrier |
Intron 22 inversion |
R |
|||
| 33-3 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 34-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 35-1 |
M |
Affected case |
Intron 22 inversion |
R |
3.0% |
moderate |
|
| 40-2 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 47-1 |
M |
Affected case |
Intron 22 inversion |
R |
3.2% |
moderate |
|
| 58-3 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 60-1 |
M |
Affected case |
Intron 22 inversion |
R |
1.6% |
moderate |
|
| 6-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 51-1 |
M |
Affected case |
Intron 22 inversion |
R |
2.7% |
moderate |
|
| 62-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 64-2 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 68-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 70-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 75-2 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 76-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 77-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 81 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 86-2 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 88-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 89-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 90 |
M |
Affected case |
Intron 22 inversion |
R |
0.8% |
severe |
|
| 91 |
M |
Affected case |
Intron 22 inversion |
R |
1.1% |
moderate |
|
| 9-1 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 96-2 |
M |
Affected case |
Intron 22 inversion |
R |
0.5% |
severe |
|
| 99 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
| 148 |
M |
Affected case |
Intron 22 inversion |
R |
<1% |
severe |
|
Lin et al. BMC Medical Genetics 2008 9:53 doi:10.1186/1471-2350-9-53 |
|||||||